530 related articles for article (PubMed ID: 28818202)
21. Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer.
Du XL; Zhang Y; Hardy D
Cancer Causes Control; 2016 May; 27(5):695-707. PubMed ID: 27059219
[TBL] [Abstract][Full Text] [Related]
22. Arterial Thromboembolism in Cancer Patients: A Danish Population-Based Cohort Study.
Mulder FI; Horváth-Puhó E; van Es N; Pedersen L; Büller HR; Bøtker HE; Sørensen HT
JACC CardioOncol; 2021 Jun; 3(2):205-218. PubMed ID: 34396325
[TBL] [Abstract][Full Text] [Related]
23. Risks of Venous Thromboembolism, Stroke, Heart Disease, and Myelodysplastic Syndrome Associated With Hematopoietic Growth Factors in a Large Population-Based Cohort of Patients With Colorectal Cancer.
Du XL; Zhang Y
Clin Colorectal Cancer; 2015 Dec; 14(4):e21-31. PubMed ID: 26119923
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
[TBL] [Abstract][Full Text] [Related]
25. Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With Cancer.
Wang J; Kim YD; Kim CH
Mayo Clin Proc; 2021 Mar; 96(3):592-600. PubMed ID: 33673912
[TBL] [Abstract][Full Text] [Related]
26. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
27. Risk of cardiac death after adjuvant radiotherapy for breast cancer.
Giordano SH; Kuo YF; Freeman JL; Buchholz TA; Hortobagyi GN; Goodwin JS
J Natl Cancer Inst; 2005 Mar; 97(6):419-24. PubMed ID: 15770005
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Olesen JB; Fauchier L; Lane DA; Taillandier S; Lip GYH
Chest; 2012 Jan; 141(1):147-153. PubMed ID: 21680645
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
30. Incidence of venous thromboembolism and its effect on survival among patients with common cancers.
Chew HK; Wun T; Harvey D; Zhou H; White RH
Arch Intern Med; 2006 Feb; 166(4):458-64. PubMed ID: 16505267
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of arterial thromboembolic events in transfusion-naïve thalassemia: a nationwide population-based study.
Liu X; Wen J; Xu Y; Ruan Y; Yi T; Chen JC; Wu X
J Investig Med; 2019 Jun; 67(5):826-832. PubMed ID: 31126995
[TBL] [Abstract][Full Text] [Related]
32. Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Primary Brain Tumors.
Parikh NS; Burch JE; Kamel H; DeAngelis LM; Navi BB
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2396-2403. PubMed ID: 28647417
[TBL] [Abstract][Full Text] [Related]
33. Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer.
Elliott SP; Fan Y; Jarosek S; Chu H; Downs L; Dusenbery K; Geller MA; Virnig BA
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):586-93. PubMed ID: 25890845
[TBL] [Abstract][Full Text] [Related]
34. Recurrent Stroke: The Value of the CHA2DS2VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort.
Andersen SD; Gorst-Rasmussen A; Lip GY; Bach FW; Larsen TB
Stroke; 2015 Sep; 46(9):2491-7. PubMed ID: 26304862
[TBL] [Abstract][Full Text] [Related]
35. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.
Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B
BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428
[TBL] [Abstract][Full Text] [Related]
36. Age- and sex-specific incidence, risk, and latency period of a perioperative acute thromboembolism syndrome (PATS).
Kikura M; Takada T; Sato S
Thromb Haemost; 2004 Apr; 91(4):725-32. PubMed ID: 15045134
[TBL] [Abstract][Full Text] [Related]
37. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
38. Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study.
Pelland-Marcotte MC; Pole JD; Kulkarni K; Athale U; Stammers D; Sabapathy C; Halparin J; Brandão LR; Sung L
Thromb Haemost; 2018 Sep; 118(9):1646-1655. PubMed ID: 30103249
[TBL] [Abstract][Full Text] [Related]
39. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
[TBL] [Abstract][Full Text] [Related]
40. Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data.
Tuohy CV; Montez-Rath ME; Turakhia M; Chang TI; Winkelman JW; Winkelmayer WC
BMC Nephrol; 2016 Feb; 17():16. PubMed ID: 26861778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]